Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dynatrace, Inc. Director's Dealing 2025

Nov 19, 2025

30410_dirs_2025-11-18_5c8e5f7c-7e4b-4862-b3fe-75cf9338cbc2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dynatrace, Inc. (DT)
CIK: 0001773383
Period of Report: 2025-11-15

Reporting Person: MCCONNELL RICK M (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-15 Common Stock M 5275 Acquired 113400 Direct
2025-11-15 Common Stock F 2679 $46.84 Disposed 110721 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-11-15 Restricted Stock Units $ M 5275 Disposed Common Stock (5275) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 500 Indirect

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting
date.

F2: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations upon the vesting of RSUs.

F3: Shares held by the Anne Marie McConnell Trust dated July 16, 2021, for which the Reporting Person's spouse is the sole trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares except to the extent of his pecuniary interest, if any, therein, and nothing contained in this report shall be deemed an admission that the Reporting Person is the beneficial owner of any of the shares for Section 16 purposes or otherwise.

F4: Represents the vesting of RSUs granted on December 13, 2021. 50% of the RSUs granted vested in two equal installments on November 15, 2022 and November 15, 2023. For the remaining 50% of
the RSUs granted, 25% vested on November 15, 2022 and the balance vested in equal quarterly installments thereafter until fully vested on November 15, 2025.